{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T16:02:06Z","timestamp":1740153726643,"version":"3.37.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"GABBIA Biotech"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics &amp; Antimicro. Prot."],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s12602-021-09900-6","type":"journal-article","created":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T01:04:23Z","timestamp":1642208663000},"page":"738-748","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bifidobacterium lactis CCT 7858 Improves Gastrointestinal Symptoms by Antibiotics Treatment: a Double-Blind, Randomized, Placebo-Controlled Trial"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8440-1976","authenticated-orcid":false,"given":"Monique","family":"Michels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"C\u00f3rneo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luana","family":"Cucker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla Sasso","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel Fernandes Alves","family":"de Jesus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Michels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristian","family":"Madeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Paula","family":"Voytena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Rossetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Ramlov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danusa","family":"de Castro Dam\u00e1sio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Dal-Pizzol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,15]]},"reference":[{"doi-asserted-by":"publisher","unstructured":"McFarland LV (2008) Antibiotic-associated diarrhea: epidemiology, trends and treatment. Future Microbiol 3:563\u2013578. https:\/\/doi.org\/10.2217\/17460913.3.5.563","key":"9900_CR1","DOI":"10.2217\/17460913.3.5.563"},{"doi-asserted-by":"publisher","unstructured":"Doron SI, Hibberd PL, Gorbach SL (2008) Probiotics for prevention of antibiotic-associated diarrhea. J Clin Gastroenterol 42:58\u201363. https:\/\/doi.org\/10.1097\/MCG.0b013e3181618ab7","key":"9900_CR2","DOI":"10.1097\/MCG.0b013e3181618ab7"},{"doi-asserted-by":"publisher","unstructured":"Bartlett JG (2002) Clinical practice: antibiotic-associated diarrhea. N Engl J Med 346:334\u2013339. https:\/\/doi.org\/10.1056\/NEJMcp011603","key":"9900_CR3","DOI":"10.1056\/NEJMcp011603"},{"doi-asserted-by":"publisher","unstructured":"Spencer RC (1998) The role of antimicrobial agents in the aetiology of Clostridium difficile-associated disease. J Antimicrob Chemother Suppl C:21\u201327. https:\/\/doi.org\/10.1093\/jac\/41.suppl_3.21","key":"9900_CR4","DOI":"10.1093\/jac\/41.suppl_3.21"},{"doi-asserted-by":"publisher","unstructured":"Bignardi GE (1998) Risk factors for Clostridium difficile infection. J Hosp Infect 40(1):1\u201315. https:\/\/doi.org\/10.1016\/s0195-6701(98)90019-6","key":"9900_CR5","DOI":"10.1016\/s0195-6701(98)90019-6"},{"doi-asserted-by":"publisher","unstructured":"H\u00f6genauer C, Hammer HF, Krejs GJ, Reisinger EC (1998) Mechanisms and management of antibiotic-associated diarrhea. Clin Infect Dis 27:702\u2013710. https:\/\/doi.org\/10.1016\/s0195-6701(98)90019-6","key":"9900_CR6","DOI":"10.1016\/s0195-6701(98)90019-6"},{"key":"9900_CR7","first-page":"53","volume":"35","author":"B Aronsson","year":"1982","unstructured":"Aronsson B, M\u00f6llby R, Nord CE (1982) Clostridium difficile and antibiotic associated diarrhoea in Sweden. Scand J Infect Dis Suppl 35:53\u201358 PMID: 6962998","journal-title":"Scand J Infect Dis Suppl"},{"doi-asserted-by":"publisher","unstructured":"McFarland LV (2008) Updates on the changing epidemiology of Clostridium difficile- associated disease. Nat Clin Pract Gastroenterology Hepatol 5:40\u201348. https:\/\/doi.org\/10.1038\/ncpgasthep1029","key":"9900_CR8","DOI":"10.1038\/ncpgasthep1029"},{"doi-asserted-by":"publisher","unstructured":"Owens RC Jr, Donskey CJ, Gaynes RP, Loo VG, Muto CA (2008) Antimicrobial associated risk factors for Clostridium difficile infection. Clin Infect Dis 2:19\u201331. https:\/\/doi.org\/10.1086\/521859","key":"9900_CR9","DOI":"10.1086\/521859"},{"doi-asserted-by":"publisher","unstructured":"Hicks C, Moore S, Andrade A, Gentry C, Taormina C (2013) Probiotics for the prevention of antibiotic-associated diarrhea. Kans 6:148\u2013151. https:\/\/doi.org\/10.17161\/kjm.v6i4.11460","key":"9900_CR10","DOI":"10.17161\/kjm.v6i4.11460"},{"unstructured":"FAO\/WHO (2001) Evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria, Food and Agriculture Organization of the United Nations and World Health Organization, joint FAO\/WHO expert consultation group: Cordoba, Argentina. Available in: https:\/\/www.fao.org\/publications\/card\/en\/c\/7c102d95-2fd5-5b22-8faf-f0b2e68dfbb6\/\u00a0Accessed in: 08 March 2021","key":"9900_CR11"},{"key":"9900_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1542\/peds.72.3.317","volume":"72","author":"H Yoshioka","year":"1983","unstructured":"Yoshioka H, Iseki K, Fujita K (1983) Development and differences of intestinal flora in the neonatal period in breast-fed and bottle-fed infants. Pediatrics 72:317\u2013321 PMID: 6412205","journal-title":"Pediatrics"},{"doi-asserted-by":"publisher","unstructured":"Benno Y, Sawada K, Mitsuoka T (1984) The intestinal microflora of infants: composition of fecal flora in breast-fed and bottle-fed infants. Microbiol Immunol 28:975\u2013986. https:\/\/doi.org\/10.1111\/j.1348-0421.1984.tb00754.x","key":"9900_CR13","DOI":"10.1111\/j.1348-0421.1984.tb00754.x"},{"doi-asserted-by":"publisher","unstructured":"Pochart P, Marteau P, Bouhnik Y et al (1992) Survival of Bifidobacteria ingested via fermented milk during their passage through the human small intestine: an in vivo study using intestinal perfusion. Am J Clin Nutr 55:78\u201380. https:\/\/doi.org\/10.1093\/ajcn\/55.1.78","key":"9900_CR14","DOI":"10.1093\/ajcn\/55.1.78"},{"doi-asserted-by":"publisher","unstructured":"Link-Amster H, Rochat F, Saudan KY et al (1994) Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol Med Microbiol 10:55\u201364. https:\/\/doi.org\/10.1111\/j.1574-695X.1994.tb00011.x","key":"9900_CR15","DOI":"10.1111\/j.1574-695X.1994.tb00011.x"},{"doi-asserted-by":"publisher","unstructured":"Fukushima Y, Li ST, Hara H et al (1997) Effect of follow-up formula containing Bifidobacteria (NAN BF) on fecal flora and fecal metabolites in healthy children. Bioscience Microflora 16: 65\u201372. https:\/\/doi.org\/10.12938\/bifidus1996.16.65","key":"9900_CR16","DOI":"10.12938\/bifidus1996.16.65"},{"doi-asserted-by":"publisher","unstructured":"Lewis SJ, Heaton KW (1997) Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 32:920\u2013924. https:\/\/doi.org\/10.3109\/00365529709011203","key":"9900_CR17","DOI":"10.3109\/00365529709011203"},{"doi-asserted-by":"publisher","unstructured":"Zhou SY, Liu T, Qin HZ et al (2013) Characteristics of commonly used scales for diagnosis and treatment outcome evaluation in constipation. World Chin J Digestol 21:2611\u20132616. https:\/\/doi.org\/10.11569\/wcjd.v21.i25.2611","key":"9900_CR18","DOI":"10.11569\/wcjd.v21.i25.2611"},{"doi-asserted-by":"publisher","unstructured":"Svedlund J, Sj\u00f6din I, Dotevall G (1988) GSRS - A clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 33:129\u2013134. https:\/\/doi.org\/10.1007\/BF01535722","key":"9900_CR19","DOI":"10.1007\/BF01535722"},{"doi-asserted-by":"publisher","unstructured":"Dimen\u00e4s E, Glise H, Hallerb\u00e4ck B, Hernqvist H, Svedlund J, Wiklund I (1993) Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scand J Gastroenterol 28:681\u2013687. https:\/\/doi.org\/10.3109\/00365529309098272","key":"9900_CR20","DOI":"10.3109\/00365529309098272"},{"doi-asserted-by":"publisher","unstructured":"Heaton KW, Radvan J, Cripps H, Mountford RA, Braddon FEM, Hughes AO (1992) Defecation frequency and timing, and stool form in the general population: a prospective study. Gut 33:818\u2013824. https:\/\/doi.org\/10.1136\/gut.33.6.818","key":"9900_CR21","DOI":"10.1136\/gut.33.6.818"},{"key":"9900_CR22","first-page":"1","volume-title":"Rome III: the functional gastrointestinal disorders","author":"DA Drossman","year":"2006","unstructured":"Drossman DA (2006) The functional gastrointestinal disorders and the Rome III. In: Drossman DA, Corazziari E, Spiller RC, Thompson WG, Delvaux M, Talley NJ, Whitehead WE (eds) Rome III: the functional gastrointestinal disorders, 3rd edn. Inc, McLean VA Degnon Associates, pp 1\u201329","edition":"3"},{"doi-asserted-by":"publisher","unstructured":"Goldenberg JZ, Yap C, Lytvyn L, Lo CK, Beardsley J, Mertz D, Johnston BC (2017) Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev 12:6095. https:\/\/doi.org\/10.1002\/14651858.CD006095.pub4","key":"9900_CR23","DOI":"10.1002\/14651858.CD006095.pub4"},{"doi-asserted-by":"publisher","unstructured":"Hempel S, Newberry SJ, Maher AR et al (2012) Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 307:1959\u20131969. https:\/\/doi.org\/10.1001\/jama.2012.3507","key":"9900_CR24","DOI":"10.1001\/jama.2012.3507"},{"doi-asserted-by":"publisher","unstructured":"Videlock EJ, Cremonini F (2012) Meta-analysis: probiotics in antibiotic-associated diarrhoea. Aliment Pharmacol Ther 35:1355\u20131369. https:\/\/doi.org\/10.1111\/j.1365-2036.2012.05104.x","key":"9900_CR25","DOI":"10.1111\/j.1365-2036.2012.05104.x"},{"doi-asserted-by":"publisher","unstructured":"Ritchie ML, Romanuk TN (2012) A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One 7:34938. https:\/\/doi.org\/10.1371\/journal.pone.0034938","key":"9900_CR26","DOI":"10.1371\/journal.pone.0034938"},{"doi-asserted-by":"publisher","unstructured":"McFarland LV (2010) Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol 16:2202\u20132222. https:\/\/doi.org\/10.3748\/wjg.v16.i18.2202.","key":"9900_CR27","DOI":"10.3748\/wjg.v16.i18.2202"},{"doi-asserted-by":"publisher","unstructured":"Johnston BC, Supina AL, Ospina M, Vohra S (2007) Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 2:CD004827. https:\/\/doi.org\/10.1002\/14651858.CD004827.pub2","key":"9900_CR28","DOI":"10.1002\/14651858.CD004827.pub2"},{"doi-asserted-by":"publisher","unstructured":"Lin JS, Chiu YH, Lin NT et al (2009) Different effects of probiotic species\/strains on infections in preschool children: a double-blind, randomized.\u00a0https:\/\/doi.org\/10.1002\/14651858.CD004827.pub2","key":"9900_CR29","DOI":"10.1002\/14651858.CD004827.pub2"},{"doi-asserted-by":"publisher","unstructured":"Binns CW, Lee AH, Harding H et al (2007) The CUPDAY study: prebiotic-probiotic milk product in 1\u20133-year-old children attending childcare centres. Acta Paediatr 96:1646\u20131650. https:\/\/doi.org\/10.1111\/j.1651-2227.2007.00508.x","key":"9900_CR30","DOI":"10.1111\/j.1651-2227.2007.00508.x"},{"doi-asserted-by":"publisher","unstructured":"Weizman Z, Asli G, Alsheikh A (2005) Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 115:5\u20139. https:\/\/doi.org\/10.1542\/peds.2004-1815","key":"9900_CR31","DOI":"10.1542\/peds.2004-1815"},{"doi-asserted-by":"publisher","unstructured":"Saavedra JM, Abi-Hanna A, Moore N et al (2004) Long-term consumption of infant formulas containing live probiotic bacteria: tolerance and safety. Am J Clin Nutr 79: 261\u2013267. https:\/\/doi.org\/10.1093\/ajcn\/79.2.261","key":"9900_CR32","DOI":"10.1093\/ajcn\/79.2.261"},{"doi-asserted-by":"publisher","unstructured":"Hojsak I, Snovak N, Abdovic S et al (2010) Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clin Nutr 29:312\u2013316. https:\/\/doi.org\/10.1016\/j.clnu.2009.09.008","key":"9900_CR33","DOI":"10.1016\/j.clnu.2009.09.008"},{"doi-asserted-by":"publisher","unstructured":"Chouraqui JP, Van Egroo LD, Fichot MC (2004) Acidified milk formula supplemented with Bifidobacterium lactis: impact on infant diarrhea in residential care settings. J Pediatr Gastroenterol Nutr 38:288\u2013292. https:\/\/doi.org\/10.1097\/00005176-200403000-00011","key":"9900_CR34","DOI":"10.1097\/00005176-200403000-00011"},{"doi-asserted-by":"publisher","unstructured":"Thibault H, Aubert-Jacquin C, Goulet O (2004) Effects of long-term consumption of a fermented infant formula (with Bifidobacterium breve c50 and Streptococcus thermophilus 065) on acute diarrhea in healthy infants. J Pediatr Gastroenterol Nutr 39:147\u2013152. https:\/\/doi.org\/10.1097\/00005176-200408000-00004","key":"9900_CR35","DOI":"10.1097\/00005176-200408000-00004"},{"doi-asserted-by":"publisher","unstructured":"Hatakka K, Savilahti E, Ponka A et al (2001) Effect of long-term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 322:1327. https:\/\/doi.org\/10.1136\/bmj.322.7298.1327","key":"9900_CR36","DOI":"10.1136\/bmj.322.7298.1327"},{"doi-asserted-by":"publisher","unstructured":"Collinson S, Deans A, Padua-Zamora A, Gregorio GV, Li C, Dans LF, Allen SJ (2020) Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev 12(12):CD003048. https:\/\/doi.org\/10.1002\/14651858","key":"9900_CR37","DOI":"10.1002\/14651858"},{"doi-asserted-by":"publisher","unstructured":"Kaku N, Matsumoto N, Sasaki D, Tsuda K, Kosai K, Uno N, Morinaga Y, Tagami A, Adachi S, Hasegawa H, Osaki M, Yanagihara K (2020) Effect of probiotics on gut microbiome in patients with administration of surgical antibiotic prophylaxis: a randomized controlled study. J Infect Chemother 26(8):795\u2013801. https:\/\/doi.org\/10.1016\/j.jiac.2020.03.008","key":"9900_CR38","DOI":"10.1016\/j.jiac.2020.03.008"},{"doi-asserted-by":"publisher","unstructured":"Ouwehand AC, Kirjavainen PV, Gronlund MM, Isolauri E, Salminen SJ (1999) Adhesion of probiotic microorganisms to intestinal mucus. Int Dairy J 9:623\u2013 630. https:\/\/doi.org\/10.1016\/j.jiac.2020.03.008","key":"9900_CR39","DOI":"10.1016\/j.jiac.2020.03.008"},{"doi-asserted-by":"publisher","unstructured":"Jungersen M, Wind A, Johansen E, Christensen JE, Stuer-Lauridsen B, Eskesen D (2014) The science behind the probiotic strain Bifidobacterium animalis subsp. lactis BB-12(\u00ae). Microorganisms 2:92\u2013110. https:\/\/doi.org\/10.3390\/microorganisms2020092","key":"9900_CR40","DOI":"10.3390\/microorganisms2020092"},{"doi-asserted-by":"publisher","unstructured":"Saavedra JM, Bauman NA, Oung I et al (1994) Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 344:1046\u20139. https:\/\/doi.org\/10.1016\/s0140-6736(94)91708-6","key":"9900_CR41","DOI":"10.1016\/s0140-6736(94)91708-6"},{"doi-asserted-by":"publisher","unstructured":"Hotta M, Sato Y, Iwata S et al (1987) Clinical effects of Bifidobacterium preparations on pediatric intractable diarrhea. Keio J Med 298\u2013314. https:\/\/doi.org\/10.1016\/s0140-6736(94)91708-6","key":"9900_CR42","DOI":"10.1016\/s0140-6736(94)91708-6"},{"doi-asserted-by":"publisher","unstructured":"Saavedra JM (1995) Microbes to fight microbes: a not so novel approach to controlling diarrheal disease. J Pediatr Gastroenterol Nutr 21:125\u2013129. https:\/\/doi.org\/10.1016\/s0140-6736(94)91708-6","key":"9900_CR43","DOI":"10.1016\/s0140-6736(94)91708-6"},{"doi-asserted-by":"publisher","unstructured":"Fukushima Y, Kawata Y, Hara H et al (1998) Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol 42:39\u201344. https:\/\/doi.org\/10.1016\/s0168-1605(98)00056-7","key":"9900_CR44","DOI":"10.1016\/s0168-1605(98)00056-7"},{"doi-asserted-by":"publisher","unstructured":"Vanderhoof JA, Young RJ (1998) Use of probiotics in childhood gastrointestinal disorders. J Pediatr Gastroenterol Nutr 27:323\u2013332. https:\/\/doi.org\/10.1097\/00005176-199809000-00011","key":"9900_CR45","DOI":"10.1097\/00005176-199809000-00011"},{"doi-asserted-by":"publisher","unstructured":"Oelschlaeger TA (2010) Mechanisms of probiotic actions \u2013 a review. Int J Med Microbiol 300:57\u201362. https:\/\/doi.org\/10.1016\/j.ijmm.2009.08.005","key":"9900_CR46","DOI":"10.1016\/j.ijmm.2009.08.005"},{"doi-asserted-by":"publisher","unstructured":"Ng SC, Hart AL, Kamm MA, Stagg AJ, Knight SC (2008) Mechanisms of action of probiotics: Recent advances. Inflamm Bowel Dis 1:300\u2013310. https:\/\/doi.org\/10.1002\/ibd.20602","key":"9900_CR47","DOI":"10.1002\/ibd.20602"},{"doi-asserted-by":"publisher","unstructured":"Waller PA, Gopal PK, Leyer GJ, Ouwehand AC, Reifer C, Stewart ME, Miller LE (2011) Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scand J Gastroenterol 46:1057\u20131064. https:\/\/doi.org\/10.3109\/00365521.2011.584895","key":"9900_CR48","DOI":"10.3109\/00365521.2011.584895"},{"doi-asserted-by":"publisher","unstructured":"Tabbers MM, Chmielewska A, Roseboom MG, Boudet C, Perrin C, Szajewska H, Benninga MA (2009) Effect of the consumption of a fermented dairy product containing Bifidobacterium lactis DN-173 010 on constipation in childhood: a multicentre randomised controlled trial (NTRTC: 1571). BMC Pediatr 9:22. https:\/\/doi.org\/10.1186\/1471-2431-9-22","key":"9900_CR49","DOI":"10.1186\/1471-2431-9-22"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-021-09900-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-021-09900-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-021-09900-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T09:05:24Z","timestamp":1685091924000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-021-09900-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,15]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["9900"],"URL":"https:\/\/doi.org\/10.1007\/s12602-021-09900-6","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"type":"print","value":"1867-1306"},{"type":"electronic","value":"1867-1314"}],"subject":[],"published":{"date-parts":[[2022,1,15]]},"assertion":[{"value":"24 December 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committees of Hospital S\u00e3o Jos\u00e9 in Crici\u00fama approved the study (Number: 4.449.750\/2020 and CAAE number: 40641120.9.0000.5364) and all patients or proxies gave written informed consent, without any refusal. The study was registered in clinical trial\u2009=\u2009NCT04742322.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All patients or proxies gave written informed consent, without any refusal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors approved final version submitted.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Gabbia Biotechnology are developing <i>B. lactis<\/i> strain for the commercial purposes. Gabriel Jesus, Marina Rosseto, Ana Paula Voytena, and Fernanda Ramlov are members of Gabbia Biotechnology. The authors declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest\/Competing Interests"}}]}}